ABIOMED Inc (NASDAQ:ABMD)
| 265.66 Delayed Data As of Jul 09 |  +0.04 / +0.02%Today’s Change | 119.01 Today|||52-Week Range 285.77 | +55.73% Year-to-Date |
Latest ABMD News | Press Releases
No recent news for ABIOMED Inc.
Today’s Trading
| Previous close | 265.64 |
| Today’s open | 267.30 |
| Day’s range | 261.01 - 268.72 |
| Volume | 257,240 |
| Average volume (3 months) | 610,150 |
| Market cap | $11.9B |
Data as of 3:59pm ET, 07/09/2020
Growth & Valuation
| Earnings growth (last year) | -22.09% |
| Earnings growth (this year) | -21.49% |
| Earnings growth (next 5 years) | +14.40% |
| Revenue growth (last year) | +9.29% |
| P/E ratio | 59.9 |
| Price/Sales | 7.91 |
| Price/Book | 11.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PODDInsulet Corp | +3.60 | +1.73% |
| TFXTeleflex Inc | +0.34 | +0.10% |
| PENPenumbra Inc | -0.06 | -0.03% |
| WSTWest Pharmaceutical ... | -0.09 | -0.04% |
Data as of 4:00pm ET, 07/09/2020
Financials
| Next reporting date | July 23, 2020 |
| EPS forecast (this quarter) | $0.33 |
| Annual revenue (last year) | $840.9M |
| Annual profit (last year) | $203.0M |
| Net profit margin | 24.14% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Danvers, Massachusetts |
Forecasts
